Historically, biotech stocks have performed reasonably well in the month of January, and this year too, it has been no different. The iShares Nasdaq Biotechnology ETF (IBB) a bellwether of investor sentiment, has so far gained nearly 16%. Listed below are some of the biotech stocks that made triple-digit gains in January, and their near-term catalysts to watch out for.
from RTT - Biotech http://bit.ly/2MMnJle
via IFTTT
No comments:
Post a Comment